BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $5,984,000 | 0.0% | 70,953 | 0.0% | 0.31% | 0.0% |
Q1 2021 | $5,984,000 | +5.6% | 70,953 | +0.4% | 0.31% | +1.6% |
Q4 2020 | $5,668,000 | -0.4% | 70,639 | -0.2% | 0.31% | -14.0% |
Q3 2020 | $5,693,000 | -7.5% | 70,787 | -1.0% | 0.36% | -13.3% |
Q2 2020 | $6,156,000 | +6.9% | 71,496 | +0.8% | 0.41% | -8.4% |
Q1 2020 | $5,759,000 | +7.0% | 70,939 | +10.2% | 0.45% | +38.5% |
Q4 2019 | $5,383,000 | -8.6% | 64,371 | -4.4% | 0.32% | -14.7% |
Q3 2019 | $5,888,000 | -15.1% | 67,313 | -20.5% | 0.38% | -15.9% |
Q2 2019 | $6,938,000 | +1.1% | 84,721 | +0.4% | 0.45% | -3.6% |
Q1 2019 | $6,864,000 | +22.5% | 84,423 | -0.8% | 0.47% | +10.8% |
Q4 2018 | $5,604,000 | -17.8% | 85,129 | -3.8% | 0.42% | +10.7% |
Q3 2018 | $6,819,000 | +2.8% | 88,451 | -1.6% | 0.38% | -1.8% |
Q2 2018 | $6,634,000 | +13.5% | 89,846 | -0.0% | 0.39% | +11.7% |
Q1 2018 | $5,845,000 | +0.9% | 89,863 | +0.2% | 0.35% | +3.3% |
Q4 2017 | $5,795,000 | +0.3% | 89,656 | -2.6% | 0.34% | -4.5% |
Q3 2017 | $5,775,000 | +0.8% | 92,043 | -2.8% | 0.35% | -1.1% |
Q2 2017 | $5,731,000 | +13.5% | 94,672 | -2.8% | 0.36% | +17.0% |
Q1 2017 | $5,050,000 | – | 97,374 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |